LONDON (Reuters) - GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the U.S. biotech group's board.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/He5v0IH7rEM/us-humangenome-gsk-idUSBRE84809U20120509
best news online money internet business Current news latest news top news
No comments:
Post a Comment